{"transactions":[{"id":2532761,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2021-10-29T00:06:52.000Z","date":"2021-10-27","kind":"sale","acquired":false,"shares":21051,"price":1.82,"value":38312.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.84, inclusive. The Reporting Person undertakes to provide to Kala Pharmaceuticals, Inc., any security holder of Kala Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 61,166 unvested RSUs."}],"balance_after":204515,"source":{"system":"sec-edgar","filing":"0001415889-21-005014","document":"form4-10282021_051044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000141588921005014/form4-10282021_051044.xml","form_type":"4"}},{"id":2532760,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2021-10-29T00:06:52.000Z","date":"2021-10-26","kind":"sale","acquired":false,"shares":9449,"price":1.8,"value":17008.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's performance-based restricted stock units (\"RSUs\") granted on June 25, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.89, inclusive. The Reporting Person undertakes to provide to Kala Pharmaceuticals, Inc., any security holder of Kala Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 61,166 unvested RSUs."}],"balance_after":225566,"source":{"system":"sec-edgar","filing":"0001415889-21-005014","document":"form4-10282021_051044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000141588921005014/form4-10282021_051044.xml","form_type":"4"}},{"id":2649725,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2021-06-30T21:30:19.000Z","date":"2021-06-29","kind":"sale","acquired":false,"shares":5548,"price":5.56,"value":30846.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.53 to $5.60, inclusive. The reporting person undertakes to provide to Kala Pharmaceuticals, Inc., any security holder of Kala Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 91,666 unvested RSUs."}],"balance_after":235015,"source":{"system":"sec-edgar","filing":"0001415889-21-003271","document":"form4-06302021_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000141588921003271/form4-06302021_050601.xml","form_type":"4"}},{"id":2651674,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2021-06-29T21:26:28.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":2452,"price":5.77,"value":14148.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on June 25, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 91,666 unvested RSUs."}],"balance_after":240563,"source":{"system":"sec-edgar","filing":"0001415889-21-003261","document":"form4-06292021_050603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000141588921003261/form4-06292021_050603.xml","form_type":"4"}},{"id":2813105,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy","published_at":"2021-03-03T22:01:37.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested."}],"balance_after":53736,"derivative":{"exercise_price":2.3,"expiration_date":"2024-10-02","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001179110-21-002694","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911021002694/edgar.xml","form_type":"4"}},{"id":2813104,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-03T22:01:37.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":9500,"price":2.3,"value":21850.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,666 unvested RSUs."}],"balance_after":243015,"source":{"system":"sec-edgar","filing":"0001179110-21-002694","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911021002694/edgar.xml","form_type":"4"}},{"id":2829610,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-26T22:35:11.000Z","date":"2021-02-25","kind":"exercise","acquired":false,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested."}],"balance_after":63236,"derivative":{"exercise_price":2.3,"expiration_date":"2024-10-02","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001179110-21-002366","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911021002366/edgar.xml","form_type":"4"}},{"id":2829609,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-26T22:35:11.000Z","date":"2021-02-25","kind":"exercise","acquired":true,"shares":47000,"price":2.3,"value":108100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 99,666 unvested RSUs."}],"balance_after":233515,"source":{"system":"sec-edgar","filing":"0001179110-21-002366","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911021002366/edgar.xml","form_type":"4"}},{"id":2920277,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-05T21:57:13.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":90667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 4, 2021 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter."}],"balance_after":90667,"derivative":{"exercise_price":6.86,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":90667},"source":{"system":"sec-edgar","filing":"0001179110-21-000182","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911021000182/edgar.xml","form_type":"4"}},{"id":2920276,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-05T21:57:13.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":22666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with Issuer, the RSUs will vest as to 1/3 of the shares underlying the RSUs on January 4, 2022, as to 1/3 of the shares underlying the RSUs on January 4, 2023 and as to the final 1/3 of shares underlying the RSUs on January 4, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 99,666 unvested RSUs."}],"balance_after":186515,"source":{"system":"sec-edgar","filing":"0001179110-21-000182","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911021000182/edgar.xml","form_type":"4"}},{"id":2998623,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-10-29T00:30:26.000Z","date":"2020-10-26","kind":"grant","acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 25, 2020, the reporting person was granted performance-based restricted stock unit (\"RSUs\") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with the Issuer, the RSUs will vest as to 50% of the shares underlying the RSUs on October 26, 2021, the first anniversary of the achievement of the performance condition, and as to the remaining 50% of the shares underlying the RSUs on October 26, 2022, the second anniversary of the achievement of the performance condition."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 77,000 unvested RSUs."}],"balance_after":163849,"source":{"system":"sec-edgar","filing":"0001179110-20-010709","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911020010709/edgar.xml","form_type":"4"}},{"id":3097524,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Comman Stock","published_at":"2020-06-30T01:31:09.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with the Issuer, the RSUs will vest as to 50% of the shares underlying the RSUs on June 25, 2021 and the remaining 50% of the shares underlying the RSUs on June 25, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,000 unvested RSUs."}],"balance_after":102849,"source":{"system":"sec-edgar","filing":"0001104659-20-078279","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000110465920078279/a4.xml","form_type":"4"}},{"id":3189511,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-01T20:43:12.000Z","date":"2020-03-30","kind":"exercise","acquired":false,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option became fully vested on July 21, 2018."}],"balance_after":75236,"derivative":{"exercise_price":2.3,"expiration_date":"2024-10-01","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001179110-20-004335","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911020004335/edgar.xml","form_type":"4"}},{"id":3189510,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-04-01T20:43:12.000Z","date":"2020-03-30","kind":"exercise","acquired":true,"shares":31000,"price":2.3,"value":71300.0,"ownership":{"direct":true},"balance_after":86849,"source":{"system":"sec-edgar","filing":"0001179110-20-004335","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911020004335/edgar.xml","form_type":"4"}},{"id":3322982,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-03T21:12:05.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 2, 2020 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter."}],"balance_after":120000,"derivative":{"exercise_price":3.84,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001179110-20-000157","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911020000157/edgar.xml","form_type":"4"}},{"id":3703975,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-04T22:02:47.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 2, 2019 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter."}],"balance_after":150000,"derivative":{"exercise_price":5.19,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-19-000459","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911019000459/edgar.xml","form_type":"4"}},{"id":4019976,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-02T22:19:27.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":5769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option with respect to these shares is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.24,"expiration_date":"2023-09-27","underlying":"Common Stock","underlying_shares":5769},"source":{"system":"sec-edgar","filing":"0001179110-18-003327","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911018003327/edgar.xml","form_type":"4"}},{"id":4019975,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-02T22:19:27.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 2, 2014 and vests over four years, with 2.0833% of the shares underlying the option vested on August 21, 2014 and an additional 2.0833% of the shares vesting at the end of each successive one-month period thereafter."}],"balance_after":106236,"derivative":{"exercise_price":2.3,"expiration_date":"2024-10-02","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001179110-18-003327","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911018003327/edgar.xml","form_type":"4"}},{"id":4019974,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-02T22:19:27.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":5769,"price":2.24,"value":12922.56,"ownership":{"direct":true},"balance_after":55849,"source":{"system":"sec-edgar","filing":"0001179110-18-003327","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911018003327/edgar.xml","form_type":"4"}},{"id":4019973,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-02T22:19:27.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":4000,"price":2.3,"value":9200.0,"ownership":{"direct":true},"balance_after":50080,"source":{"system":"sec-edgar","filing":"0001179110-18-003327","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911018003327/edgar.xml","form_type":"4"}},{"id":4068543,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-09T21:31:08.000Z","date":"2018-02-07","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 7, 2018 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter."}],"balance_after":70000,"derivative":{"exercise_price":12.86,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001179110-18-001890","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911018001890/edgar.xml","form_type":"4"}},{"id":4253260,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":134132,"kind":"person","name":"Chen Hongming","position":1,"cik":"0001710697","reported_name":"Chen Hongming","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-21T20:22:11.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":28800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted, effective on July 19, 2017 and vests over four years, with 2.0833% of the shares underlying the option vesting on August 31, 2017 and an additional 2.0833% of the shares vesting at the end of each successive one-month period thereafter."}],"balance_after":28800,"derivative":{"exercise_price":15,"expiration_date":"2027-07-18","underlying":"Common Stock","underlying_shares":28800},"source":{"system":"sec-edgar","filing":"0001179110-17-010599","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911017010599/edgar.xml","form_type":"4"}}]}